These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 921089)

  • 21. [Myasthenia gravis caused by D-penicillamine].
    Sanz Gallego PJ; Pérez Sánchez FC; López Vázquez A; Salgado Palacio D
    Aten Primaria; 1996 Mar; 17(5):364-5. PubMed ID: 8722166
    [No Abstract]   [Full Text] [Related]  

  • 22. Reduced sulphoxidation capacity in D-penicillamine induced myasthenia gravis.
    Seideman P; Ayesh R
    Clin Rheumatol; 1994 Sep; 13(3):435-7. PubMed ID: 7835005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [D-penicillamine induced myasthenia gravis in a patient with rheumatoid arthritis].
    Kuriyama S; Hosoya T; Sakai O
    Ryumachi; 1991 Jun; 31(3):298-302; discussion 302-3. PubMed ID: 1948449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penicillamine-induced myasthenia gravis.
    Sundstrom WR; Schuna AA
    Arthritis Rheum; 1979 Feb; 22(2):197-8. PubMed ID: 420710
    [No Abstract]   [Full Text] [Related]  

  • 25. D-penicillamine-induced myasthenia gravis: diagnosis obscured by coexisting chronic obstructive pulmonary disease.
    Adelman HM; Winters PR; Mahan CS; Wallach PM
    Am J Med Sci; 1995 Apr; 309(4):191-3. PubMed ID: 7900739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myasthenia gravis and penicillamine therapy of rheumatoid arthritis.
    Bocanegra T; Espinoza LR; Vasey FB; Germain BF
    JAMA; 1980 Oct; 244(16):1822-3. PubMed ID: 7420683
    [No Abstract]   [Full Text] [Related]  

  • 27. Penicillamine-induced myasthenia gravis associated with antibodies to acetylcholine receptor.
    Russell AS; Lindstrom JM
    Neurology; 1978 Aug; 28(8):847-9. PubMed ID: 567304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Myasthenia during treatment of rheumatoid polyarthritis with D-penicillamine].
    Carter H; Job-Deslandre C; Delrieu F; Menkes CJ
    Therapie; 1984; 39(6):689-95. PubMed ID: 6531741
    [No Abstract]   [Full Text] [Related]  

  • 29. D-penicillamine and gold salt treatments were complicated by myasthenia and pemphigus, respectively, in the same patient with rheumatoid arthritis.
    Ciompi ML; Marchetti G; Bazzichi L; Puccetti L; Agelli M
    Rheumatol Int; 1995; 15(3):95-7. PubMed ID: 8588126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Penicillamine-induced myasthenia gravis.
    Myers A; Songcharoen S; Harisdangkul V
    J Miss State Med Assoc; 1984 Feb; 25(2):27-8. PubMed ID: 6699910
    [No Abstract]   [Full Text] [Related]  

  • 31. Unilateral ptosis as an initial manifestation of D-penicillamine induced myasthenia gravis.
    Raynauld JP; Lee YS; Kornfeld P; Fries JF
    J Rheumatol; 1993 Sep; 20(9):1592-3. PubMed ID: 8164222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Myasthenia induced by D-penicillamine. Apropos of 2 case reports].
    Huaux JP; Delreux V
    Acta Neurol Belg; 1986; 86(5):297-303. PubMed ID: 3492852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Myasthenia induced by D-penicillamine during the treatment of rheumatoid polyarthritis].
    Carter H; Job-Deslandre C; Delrieu F; Kahan A; Menkès CJ
    Rev Rhum Mal Osteoartic; 1986 May; 53(5):341-4. PubMed ID: 3738397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Letter: Myasthenia and autoimmune thyroiditis during rheumatoid polyarthritis treated by D-penicillamine].
    Delrieu F; Menkes CJ; Sainte-Croix A; Delbarre F; Babinet P; Chesneau AM
    Nouv Presse Med; 1975 Nov; 4(40):2890(1). PubMed ID: 1215207
    [No Abstract]   [Full Text] [Related]  

  • 35. Myasthenia gravis as a complication of D-penicillamine therapy in rheumatoid arthritis.
    Wysocka K; Fabian F; Listewnik M
    Z Rheumatol; 1981; 40(3):135-7. PubMed ID: 7282112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Myasthenia gravis associated with penicillamine treatment].
    Medrano San Ildefonso M; Mauri Llerda JA; Orte Martínez J
    Arch Neurobiol (Madr); 1987; 50(4):272-3. PubMed ID: 3662740
    [No Abstract]   [Full Text] [Related]  

  • 37. [Myasthenia gravis and autoimmune thyroiditis during the treatment of rheumatoid polyarthritis withD-penicillamine. Anatomoclinical study of 1 case].
    Delrieu F; Menkes CJ; Sainte-Croix A; Babinet P; Chesneau AM; Delbarre F
    Ann Med Interne (Paris); 1976 Oct; 127(10):739-43. PubMed ID: 1008366
    [No Abstract]   [Full Text] [Related]  

  • 38. D-penicillamine induced myasthenia gravis in rheumatoid arthritis: an unpredictable common occurrence?
    Andonopoulos AP; Terzis E; Tsibri E; Papasteriades CA; Papapetropoulos T
    Clin Rheumatol; 1994 Dec; 13(4):586-8. PubMed ID: 7697959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D-penicillamine and the ocular myasthenic syndrome.
    Kimbrough RL; Mewis L; Stewart RH
    Ann Ophthalmol; 1981 Oct; 13(10):1171-2. PubMed ID: 7316342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Myasthenia syndrome after peroral treatment with penicillamine].
    Francois J; Verbraeken H; Gabriel P; Wille C
    Ophthalmologica; 1978; 177(2):88-91. PubMed ID: 745827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.